Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 August 2022 | Story Anthony Mthembu | Photo Supplied
Day-residence representatives hard at work during the outreach programme aimed at attracting off-campus students to join any of the several day residences.

The impact of COVID-19 on students who started their studies at the UFS in 2020 and 2021, is the fact that they had to experience the UFS student life virtually. As such, the ability to experience day-residence culture was minimal.
Consequently, the SRC: Day Residences, Nontando Kalipa, along with representatives from the seven day residences and the SRC, visited off-campus accommodation as a means to market day residences. The initiative ran from 1 to 4 August 2022. “We went to various communes and other student accommodation such as Quattro, CampusKey, and ResPublica, and explained our mandate as SRC: Day Residences to the off-campus students,” Kalipa expressed.

The Importance of the Initiative

According to Kalipa, there is a lack of knowledge about the role and relevance of day residences in student life; this was seen in the responses received from some of the off-campus students who were approached during the outreach. “We came across some students who had never heard of day residences, and others who knew of them but didn’t really understand their function,” stated Kalipa. Therefore, she insisted that representatives from the respective day residences should also be involved in the initiative. “The RC primes were there specifically to share their experiences about day residences with off-campus students,” said Kalipa.

The Relevance of Day Residences in Student Life

“Day residences offer a holistic student experience, so off-campus students can expect any of the seven day residences to assist them in becoming well-rounded individuals,” expressed Corbin Butler, the incoming SRC for Day Residences. These spaces offer off-campus students access to cultural and sporting activities, such as Stagedoor, SingOff, and basketball tournaments, among others. On-campus students have the advantage of being exposed to other students from all walks of life and interacting with them consistently. As such, Butler maintains that day residences aim to bridge the existing gap by creating that very same experience for off-campus students. “We don’t want you to just get a degree and leave, we also want to capacitate you with life skills, and that’s the benefit of being part of a day residence,” Butler stated.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept